Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
One of the key challenges during this transition is the management of the washout period between semaglutide and tirzepatide, which is a necessary maneuver to minimize the risk of having overlapping side effects, as well as to prevent a decrease in the drugs efficacy
Both are GLP-1 medications, but Ozempic is taken weekly and may be stronger
Hypoglycemia risk from dulaglutide alone is low because its insulin-stimulating effect is glucose-dependent
Weve been talking a lot about GLP-1 this year
However, always consult with a healthcare professional if you have concerns
Spending on these medications accounts for a notable proportion of pharmacy spending overall: in 2022 (the latest full year of data), spending on GLP-1 drugs among commercially-insured members accounted for 5% of pharmacy spending among commercially-insured members overall
US$ 26.74
US$ 26.66
US$ 29.15
US$ 23.80
US$ 26.03
US$ 19.98
